한글목차

세계의 산업용 미생물 QC 시장은 2024년 29억 8,000만 달러로 평가되었으며, CAGR 9.33%로 확대되어, 2030년까지 50억 5,000만 달러에 달할 것으로 예측되고 있습니다.

세계의 산업용 미생물 품질 관리(QC) 시장은 산업이 제품의 안전성, 품질, 컴플라이언스를 확보하는 것에 중점을 두면서 급속히 발전하고 있습니다. 신속한 감지 및 자동화 시스템과 같은 검사 기술의 발전은 기업의 품질 보증에 대한 접근 방식을 변화시키고 있습니다. 또한 복잡한 규제 프레임워크에 따른 비용 효율적인 전문가 주도 솔루션의 필요성으로 미생물 검사를 전문 서비스 제공업체에게 위탁하는 조직도 늘어나고 있습니다. 숙련된 인재의 필요성과 최신기술의 도입에 필요한 초기 투자 등 시장은 일정한 과제에 직면하고 있습니다.

시장 성장 촉진요인

제품의 안전과 소비자의 건강에 대한 관심 증가

주요 시장 과제

첨단 기술의 높은 비용

주요 시장 동향

신속 미생물 검사법(RMM)의 채용

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 산업용 미생물 QC 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 유형별(PCR, 생물 발광, 플로우 사이토메트리, 막 여과, 형광, 비색법, 기타)
  • 용도별(제품검사기관, 연구 및 학술기관, 제약 및 바이오테크놀러지기업, 규제 및 환경기관, 음식식품기업, 기타)
  • 지역별
  • 기업별(2022년)
• 제품 맵

제6장 북미의 산업용 미생물 QC 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미: 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 산업용 미생물 QC 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽: 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 산업용 미생물 QC 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양: 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 산업용 미생물 QC 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 산업용 미생물 QC 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카: 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 제약산업에 있어서의 미생물학 품질관리 수요 증가
• 실시간 환경 모니터링에 대한 의식이 높아짐
• 과제
• 품질 관리 프로세스의 고비용
• 숙련된 전문가의 부족

제12장 시장 동향과 발전

• 합병과 인수
• 제품 출시

제13장 세계의 산업용 미생물 QC 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 산업 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• 3M Company
• Becton, Dickinson and Company
• Bio-Rad Laboratories,Inc
• Biolog,Inc.
• bioMerieux SA
• Bruker Corporation
• BIOTECON Diagnostics GmbH
• Charles River Laboratories International, Inc
• Danaher Corporation
• F. Hoffmann-La Roche Ltd

제16장 전략적 제안

제17장 기업 소개와 면책사항

영문목차

Global Industrial Microbiological QC Market was valued at USD 2.98 billion in 2024 and is expected to reach USD 5.05 billion by 2030 with a CAGR of 9.33% during the forecast period. The global industrial microbiological quality control (QC) market is evolving rapidly as industries place greater emphasis on ensuring the safety, quality, and compliance of their products. Across sectors like pharmaceuticals, food and beverages, cosmetics, and environmental monitoring, there is a growing reliance on microbiological QC processes to detect and control contamination risks throughout the production cycle. Advances in testing technologies, such as rapid detection methods and automated systems, are transforming how companies approach quality assurance. These innovations provide quicker, more accurate results, enabling proactive responses and minimizing potential disruptions. The trend toward integrating digital solutions is enhancing traceability and efficiency in QC workflows. Organizations are also increasingly outsourcing microbiological testing to specialized service providers, driven by the need for cost-effective, expert-led solutions that align with complex regulatory frameworks. In emerging markets, industrial growth and rising awareness of quality standards are fueling adoption of QC practices. However, the market faces certain challenges, including the need for skilled personnel and the initial investment required for adopting modern technologies. Despite these hurdles, the continuous push for higher quality standards and the demand for safe, compliant products are propelling the market forward, positioning microbiological QC as a vital component of modern industrial operations.

Key Market Drivers

Growing Focus on Product Safety and Consumer Health

The growing focus on product safety and consumer health is a major driving force behind the expansion of the global industrial microbiological quality control (QC) market. With heightened awareness of the health risks associated with microbial contamination, industries are under increasing pressure to ensure that their products meet high standards of cleanliness, sterility, and safety. In October 2023, NAMSA acquired U.S. and UK-based CRO, Perfectus Biomed Group. This acquisition is intended to enhance microbiology services and expand NAMSA's global presence, with 20 locations offering laboratory services across the U.S., Europe, and Asia.

Consumers today are more informed and discerning, demanding transparency, accountability, and assurance from manufacturers across sectors such as pharmaceuticals, food and beverages, cosmetics, and personal care. Any lapse in microbiological quality can lead to serious health consequences, loss of consumer trust, legal liabilities, and significant financial losses from recalls or damaged brand reputation.

As a result, manufacturers are placing greater emphasis on proactive quality control measures to detect and eliminate microbial threats at every stage of the production process. This shift is not only reactive to past contamination incidents but is increasingly preventive in nature. Companies are investing in sophisticated testing equipment and integrating real-time monitoring systems to catch contamination early and ensure that products leaving their facilities are safe for consumption or use. These practices help avoid costly recalls, meet regulatory standards, and safeguard consumer wellbeing.

Governments and health authorities around the world are tightening regulations and compliance requirements, further reinforcing the importance of robust microbiological QC systems. This heightened regulatory oversight is compelling industries to adopt best practices in testing, documentation, and traceability to ensure consistent quality and safety. The growing prioritization of consumer health is also fostering innovation in testing technologies, pushing for more rapid, accurate, and automated QC solutions. Overall, this intense focus on product safety and consumer health is transforming microbiological QC from a basic compliance function to a strategic pillar of brand integrity and operational excellence, making it a critical component in the global industrial landscape.

Key Market Challenges

High Cost of Advanced Technologies

The high cost of advanced technologies presents a significant challenge in the global industrial microbiological quality control (QC) market. As industries increasingly demand faster, more accurate, and automated microbial testing methods, the shift from traditional culture-based techniques to advanced systems-such as polymerase chain reaction (PCR), biosensors, automated microbial detection platforms, and real-time monitoring-requires substantial investment. These technologies, while offering notable improvements in efficiency and precision, often come with high initial acquisition costs, as well as ongoing expenses related to maintenance, software updates, calibration, and consumables.

For many companies, especially small and medium-sized enterprises (SMEs), the financial burden of adopting such systems can be prohibitive. Budget constraints often lead organizations to continue relying on manual or slower testing methods, which may compromise efficiency and delay product release cycles. Even larger corporations may be cautious about upgrading existing infrastructure, especially if return on investment is not immediately clear. The cost issue is particularly pronounced in developing markets, where access to capital and technical expertise may be limited, further slowing the adoption of modern QC technologies.

In addition to equipment costs, implementing advanced microbiological QC systems often requires investment in workforce training, laboratory redesign, and integration with digital quality management systems. These added layers of expense and operational disruption can make the transition daunting. Regulatory compliance and method validation for new technologies can also add complexity and cost to the process, as companies must ensure that any new system meets the required safety and performance standards before it can be deployed in routine operations.

Despite these hurdles, the long-term benefits of advanced technologies-such as reduced risk of contamination, faster turnaround times, and enhanced traceability-make them an attractive investment. However, overcoming the financial barrier remains a key challenge that could influence the pace of innovation and adoption across the microbiological QC market.

Key Market Trends

Adoption of Rapid Microbiological Methods (RMM)

The adoption of Rapid Microbiological Methods (RMM) is significantly influencing the growth trajectory of the global industrial microbiological quality control (QC) market. RMMs, including technologies like polymerase chain reaction (PCR), biosensors, and automated microbial detection systems, are transforming traditional QC practices by offering faster, more accurate, and high-throughput analysis of microbial samples.

One of the primary drivers for the adoption of RMMs is the increasing demand for rapid and precise diagnostics across various industries. In clinical settings, the need for timely identification of pathogens is crucial for effective patient management, especially in the context of rising infectious diseases and antibiotic resistance. Similarly, in the pharmaceutical and food industries, ensuring product safety and compliance with stringent regulatory standards necessitates efficient and reliable microbiological testing methods.

Technological advancements have played a pivotal role in the proliferation of RMMs. Innovations in molecular diagnostics, automation, and real-time monitoring have enhanced the sensitivity, accuracy, and throughput of microbial testing, enabling industries to streamline their QC processes and reduce time-to-result. These advancements not only improve operational efficiency but also contribute to cost savings by minimizing the need for extensive manual interventions and reducing the risk of contamination-related recalls.

The integration of digital technologies, such as artificial intelligence (AI) and machine learning (ML), into RMMs is propelling the market forward. AI and ML algorithms can analyze complex microbial data, identify patterns, and predict potential contamination risks, thereby enhancing decision-making processes and enabling proactive quality control measures. The adoption of Rapid Microbiological Methods is a transformative trend in the industrial microbiological QC market. By enabling faster, more accurate, and efficient microbial testing, RMMs are not only enhancing product safety and regulatory compliance but also driving innovation and growth across various industries.

Key Market Players

• 3M Company
• Becton, Dickinson and Company
• Bio-Rad Laboratories,Inc
• Biolog,Inc.
• bioMerieux SA
• Bruker Corporation
• BIOTECON Diagnostics GmbH
• Charles River Laboratories International, Inc
• Danaher Corporation
• F. Hoffmann-La Roche Ltd

Report Scope:

In this report, the Global Industrial Microbiological QC Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Industrial Microbiological QC Market, By Type:

• PCR
• Bioluminescence
• Flow Cytometry
• Membrane Filtration
• Fluorescence
• Colorimetry
• Others

Industrial Microbiological QC Market, By Application:

• Product Testing Laboratories
• Research and Academic Institutions
• Pharmaceutical and Biotechnology Companies
• Regulatory and Environmental Agencies
• Food and Beverage Companies
• Others

Industrial Microbiological QC Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Industrial Microbiological QC Market.

Available Customizations:

Global Industrial Microbiological QC Market report with the given market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Industrial Microbiological QC Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (PCR, Bioluminescence, Flow Cytometry, Membrane Filtration, Fluorescence, Colorimetry, Others)
  • 5.2.2. By Application (Product Testing Laboratories, Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Regulatory and Environmental Agencies, Food and Beverage Companies, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Product Map

6. North America Industrial Microbiological QC Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (PCR, Bioluminescence, Flow Cytometry, Membrane Filtration, Fluorescence, Colorimetry, Others)
  • 6.2.2. By Application (Product Testing Laboratories, Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Regulatory and Environmental Agencies, Food and Beverage Companies, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Industrial Microbiological QC Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Industrial Microbiological QC Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Industrial Microbiological QC Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Industrial Microbiological QC Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (PCR, Bioluminescence, Flow Cytometry, Membrane Filtration, Fluorescence, Colorimetry, Others)
  • 7.2.2. By Application (Product Testing Laboratories, Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Regulatory and Environmental Agencies, Food and Beverage Companies, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Industrial Microbiological QC Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Industrial Microbiological QC Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Industrial Microbiological QC Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Industrial Microbiological QC Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Industrial Microbiological QC Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Industrial Microbiological QC Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (PCR, Bioluminescence, Flow Cytometry, Membrane Filtration, Fluorescence, Colorimetry, Others)
  • 8.2.2. By Application (Product Testing Laboratories, Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Regulatory and Environmental Agencies, Food and Beverage Companies, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Industrial Microbiological QC Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Industrial Microbiological QC Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Industrial Microbiological QC Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Industrial Microbiological QC Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Industrial Microbiological QC Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Industrial Microbiological QC Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (PCR, Bioluminescence, Flow Cytometry, Membrane Filtration, Fluorescence, Colorimetry, Others)
  • 9.2.2. By Application (Product Testing Laboratories, Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Regulatory and Environmental Agencies, Food and Beverage Companies, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Industrial Microbiological QC Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Industrial Microbiological QC Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Industrial Microbiological QC Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Industrial Microbiological QC Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (PCR, Bioluminescence, Flow Cytometry, Membrane Filtration, Fluorescence, Colorimetry, Others)
  • 10.2.2. By Application (Product Testing Laboratories, Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Regulatory and Environmental Agencies, Food and Beverage Companies, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Industrial Microbiological QC Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Industrial Microbiological QC Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Industrial Microbiological QC Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.1.1 Growing Demand for Microbiology Quality Control in Pharmaceutical Industry
• 11.1.2 Growing Awareness About Real Time Environmental Monitoring
• 11.2. Challenges
• 11.2.1 High Cost of Quality Control Process
• 11.2.2 Lack of Skilled Professionals

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Industrial Microbiological QC Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 3M Company
• 15.2. Becton, Dickinson and Company
• 15.3. Bio-Rad Laboratories,Inc
• 15.4. Biolog,Inc.
• 15.5. bioMerieux SA
• 15.6. Bruker Corporation
• 15.7. BIOTECON Diagnostics GmbH
• 15.8. Charles River Laboratories International, Inc
• 15.9. Danaher Corporation
• 15.10. F. Hoffmann-La Roche Ltd

16. Strategic Recommendations

17. About Us & Disclaimer